Medical management of patients with peripheral arterial disease

Result code in IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00023001%3A_____%2F15%3A00059345" target="_blank" >RIV/00023001:_____/15:00059345 - isvavai.cz</a>

Result on the web

<a href="http://www.minervamedica.it/en/journals/international-angiology/article.php?cod=R34Y2015N01A0075" target="_blank" >http://www.minervamedica.it/en/journals/international-angiology/article.php?cod=R34Y2015N01A0075</a>

DOI - Digital Object Identifier

—

Result language

angličtina

Original language name

Medical management of patients with peripheral arterial disease

Original language description

Peripheral arterial disease (PAD) is one of the most frequent manifestations of atherosclerosis and is associated with atherosclerosis in the coronary and carotid arteries, leading to a highly increased incidence of cardiovascular events. Major risk factors of PAD are similar to those that lead to atherosclerosis in other vascular beds. However, there are differences in the power of individual risk factors in the different vascular territories. Cigarette smoking and diabetes mellitus represent the greatest risks of PAD. For prevention of the progression of PAD and accompanying cardiovascular events similar preventative measures are used as in coronary artery disease (CAD). However, recent data indicate that there are some differences in the efficacy of drugs used in the prevention of atherotbrombotic events in PAD. Antiplatelet treatment is indicated in virtually all patients with PAD. In spite of the absence of hard evidence- based data on the long term efficacy of aspirin, it is still considered as a first line treatment and clopidogrel as an effective alternative. The new antiplatelet drugs ticagrelol and prasugrel also represent promising options for treatment of PAD. SW:in therapy is indicated to achieve the target low density lipoprotein cholesterol level of {= 2.5 mmol/L (100 mg/dL) and there is emerging evidence that lower levels are more effective. Statins may also improve walking capacity Antihypertensive treatment is indicated to achieve the goal blood pressure (<140/90 mmHg).

Czech name

—

Czech description

—

Type

J_x - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)

CEP classification

FA - Cardiovascular diseases including cardio-surgery

OECD FORD branch

—

Project

—

Continuities

N - Vyzkumna aktivita podporovana z neverejnych zdroju

Publication year

2015

Confidentiality

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Name of the periodical

International Angiology

ISSN

0392-9590

e-ISSN

—

Volume of the periodical

34

Issue of the periodical within the volume

1

Country of publishing house

IT - ITALY

Number of pages

19

Pages from-to

75-93

UT code for WoS article

000352049300010

EID of the result in the Scopus database

—